|
1
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cotter TG: Apoptosis and cancer: The
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fulda S and Vucic D: Targeting IAP
proteins for therapeutic intervention in cancer. Nat Rev Drug
Discov. 11:109–124. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schimmer AD, Dalili S, Batey RA and Riedl
SJ: Targeting XIAP for the treatment of malignancy. Cell Death
Differ. 13:179–188. 2006. View Article : Google Scholar
|
|
5
|
Kaufmann T, Strasser A and Jost PJ: Fas
death receptor signalling: Roles of Bid and XIAP. Cell Death
Differ. 19:42–50. 2012. View Article : Google Scholar :
|
|
6
|
Van den Abeele P and Bertrand MJ: The role
of the IAP E3 ubiquitin ligases in regulating pattern-recognition
receptor signalling. Nat Rev Immunol. 12:833–844. 2012. View Article : Google Scholar
|
|
7
|
Qin S, Yang C, Li S, Xu C, Zhao Y and Ren
H: Smac: Its role in apoptosis induction and use in lung cancer
diagnosis and treatment. Cancer Lett. 318:9–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morizane Y, Honda R, Fukami K and Yasuda
H: X-linked inhibitor of apoptosis functions as ubiquitin ligase
toward mature caspase-9 and cytosolic Smac/DIABLO. J Biochem.
137:125–132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Flanagan L, Sebastià J, Tuffy LP, Spring
A, Lichawska A, Devocelle M, Prehn JH and Rehm M: XIAP impairs Smac
release from the mitochondria during apoptosis. Cell Death Dis.
1:e492010. View Article : Google Scholar
|
|
10
|
Li S, Sun J, Yang J, Zhang L, Wang L, Wang
X and Guo Z: XIAP expression is associated with pancreatic
carcinoma outcome. Mol Clin Oncol. 1:305–308. 2013.
|
|
11
|
Yi XP, Han T, Li YX, Long XY and Li WZ:
Simultaneous silencing of XIAP and survivin causes partial
mesenchymal-epithelial transition of human pancreatic cancer cells
via the PTEN/PI3K/Akt pathway. Mol Med Rep. 12:601–608.
2015.PubMed/NCBI
|
|
12
|
Zhao YC, Wang Y, Ni XJ, Li Y, Wang XM, Zhu
YY and Luo CY: Clinical significance of Smac and survivin
expression in breast cancer patients treated with
anthracycline-based neoadjuvant chemotherapy. Mol Med Rep.
9:614–620. 2014.
|
|
13
|
Shintani M, Sangawa A, Yamao N and
Kamoshida S: Smac/DIABLO expression in human gastrointestinal
carcinoma: Association with clinicopathological parameters and
survivin expression. Oncol Lett. 8:2581–2586. 2014.PubMed/NCBI
|
|
14
|
Qu Y, Xia P, Zhang S, Pan S and Zhao J:
Silencing XIAP suppresses osteosarcoma cell growth, and enhances
the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Oncol Rep. 33:1177–1184. 2015.PubMed/NCBI
|
|
15
|
Li M, Song T, Yin ZF and Na YQ: XIAP as a
prognostic marker of early recurrence of nonmuscular invasive
bladder cancer. Chin Med J (Engl). 120:469–473. 2007.
|
|
16
|
Mizutani Y, Nakanishi H, Li YN, Matsubara
H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara
K, et al: Overexpression of XIAP expression in renal cell carcinoma
predicts a worse prognosis. Int J Oncol. 30:919–925.
2007.PubMed/NCBI
|
|
17
|
Zhang Y, Zhu J, Tang Y, Li F, Zhou H, Peng
B, Zhou C and Fu R: X-linked inhibitor of apoptosis positive
nuclear labeling: A new independent prognostic biomarker of breast
invasive ductal carcinoma. Diagn Pathol. 6:492011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao ST, Gui SQ and Lin MS: Relationship
between expression of Smac and Survivin and apoptosis of primary
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int.
5:580–583. 2006.PubMed/NCBI
|
|
19
|
Kempkensteffen C, Jäger T, Bub J, Weikert
S, Hinz S, Christoph F, Krause H, Schostak M, Miller K and Schrader
M: The equilibrium of XIAP and Smac/DIABLO expression is gradually
deranged during the development and progression of testicular germ
cell tumours. Int J Androl. 30:476–483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan Y, Mahotka C, Heikaus S, Shibata T,
Wethkamp N, Liebmann J, Suschek CV, Guo Y, Gabbert HE, Gerharz CD,
et al: Disturbed balance of expression between XIAP and Smac/DIABLO
during tumour progression in renal cell carcinomas. Br J Cancer.
91:1349–1357. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shibata T, Mahotka C, Wethkamp N, Heikaus
S, Gabbert HE and Ramp U: Disturbed expression of the apoptosis
regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas.
Diagn Mol Pathol. 16:1–8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin S, Xu C, Li S, Wang X, Sun X, Wang P,
Zhang B and Ren H: Hyperthermia induces apoptosis by targeting
Survivin in esophageal cancer. Oncol Rep. 34:2656–2664.
2015.PubMed/NCBI
|
|
23
|
Arellano-Llamas A, Garcia FJ, Perez D,
Cantu D, Espinosa M, De la Garza JG, Maldonado V and
Melendez-Zajgla J: High Smac/DIABLO expression is associated with
early local recurrence of cervical cancer. BMC Cancer. 6:2562006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fandy TE, Shankar S and Srivastava RK:
Smac/DIABLO enhances the therapeutic potential of chemotherapeutic
drugs and irradiation, and sensitizes TRAIL-resistant breast cancer
cells. Mol Cancer. 7:602008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McNeish IA, Bell S, McKay T, Tenev T,
Marani M and Lemoine NR: Expression of Smac/DIABLO in ovarian
carcinoma cells induces apoptosis via a caspase-9-mediated pathway.
Exp Cell Res. 286:186–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maas C, Verbrugge I, de Vries E, Savich G,
van de Kooij LW, Tait SW and Borst J: Smac/DIABLO release from
mitochondria and XIAP inhibition are essential to limit
clonogenicity of Type I tumor cells after TRAIL receptor
stimulation. Cell Death Differ. 17:1613–1623. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mao HL, Liu PS, Zheng JF, Zhang PH, Zhou
LG, Xin G and Liu C: Transfection of Smac/DIABLO sensitizes
drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis
in vitro. Pharmacol Res. 56:483–492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin S, Yang C, Wang X, Xu C, Li S, Zhang B
and Ren H: Overexpression of Smac promotes Cisplatin-induced
apoptosis by activating caspase-3 and caspase-9 in lung cancer A549
cells. Cancer Biother Radiopharm. 28:177–182. 2013. View Article : Google Scholar
|
|
29
|
Qin S, Xu C, Li S, Yang C, Sun X, Wang X,
Tang SC and Ren H: Indomethacin induces apoptosis in the EC109
esophageal cancer cell line by releasing second
mitochondria-derived activator of caspase and activating caspase-3.
Mol Med Rep. 11:4694–4700. 2015.PubMed/NCBI
|
|
30
|
Hunter AM, Kottachchi D, Lewis J, Duckett
CS, Korneluk RG and Liston P: A novel ubiquitin fusion system
bypasses the mitochondria and generates biologically active
Smac/DIABLO. J Biol Chem. 278:7494–7499. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vucic D, Dixit VM and Wertz IE:
Ubiquitylation in apoptosis: A post-translational modification at
the edge of life and death. Nat Rev Mol Cell Biol. 12:439–452.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu S and Yang X: Cellular inhibitor of
apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer
Smac/DIABLO. J Biol Chem. 278:10055–10060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hao Y, Sekine K, Kawabata A, Nakamura H,
Ishioka T, Ohata H, Katayama R, Hashimoto C, Zhang X, Noda T, et
al: Apollon ubiquitinates SMAC and caspase-9, and has an essential
cytoprotection function. Nat Cell Biol. 6:849–860. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
MacFarlane M, Merrison W, Bratton SB and
Cohen GM: Proteasome-mediated degradation of Smac during apoptosis:
XIAP promotes Smac ubiquitination in vitro. J Biol Chem.
277:36611–36616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McNeish IA, Lopes R, Bell SJ, McKay TR,
Fernandez M, Lockley M, Wheatley SP and Lemoine NR: Survivin
interacts with Smac/DIABLO in ovarian carcinoma cells but is
redundant in Smac-mediated apoptosis. Exp Cell Res. 302:69–82.
2005. View Article : Google Scholar
|
|
36
|
Yang QH and Du C: Smac/DIABLO selectively
reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and
livin in HeLa cells. J Biol Chem. 279:16963–16970. 2004. View Article : Google Scholar : PubMed/NCBI
|
